Maintenance fees coming due
5 maintenance fees come due in the 12 months from Nov 21, 2026, the next on Dec 18, 2026. Unpaid by Jun 21, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5
and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the
six month grace period that follows.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Fee due | Lapses if unpaid | Expires | Confidence |
|---|---|---|---|---|---|---|---|
| US 10,323,040 | Process for the Preparation of 5-Fluorotryptophol In force Fee due Dec 18, 2026 Lapses if unpaid Jun 21, 2027 · High confidence | Adneuris Therapeutics, Inc. | In force | Dec 18, 2026 | Jun 21, 2027 | High confidence | |
| US 9,289,416 | Pharmaceutical Dosage Forms Comprising 6'-Fluoro-(N-Methyl- or N,N-Dimethyl-)-4-Phenyl-4',9'-Dihydro-3'H-Spiro[Cyclohexane-1,1'-Pyrano[3,4,b]Indol]-4-Amine In force Fee due Sep 22, 2027 Lapses if unpaid Mar 22, 2028 · High confidence | Adneuris Therapeutics, Inc. | In force | Sep 22, 2027 | Mar 22, 2028 | High confidence | |
| US 9,308,196 | Pharmaceutical composition comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine and an oxicam In force Fee due Oct 12, 2027 Lapses if unpaid Apr 12, 2028 · High confidence | Adneuris Therapeutics, Inc. | In force | Oct 12, 2027 | Apr 12, 2028 | High confidence | |
| US 9,320,725 | Pharmaceutical Composition Comprising (1R,4R)-6'-Fluoro-N,N-DIMETHYL-4-Phenyl-4'9'-Dihydro-3'H-SPIRO[CYCLOHEXANE-1,1'-Pyrano[3,4,B]INDOL]-4-Amine and a Gabapentinoid In force Fee due Oct 26, 2027 Lapses if unpaid Apr 26, 2028 · High confidence | Adneuris Therapeutics, Inc. | In force | Oct 26, 2027 | Apr 26, 2028 | High confidence | |
| US 9,320,729 | Pharmaceutical Composition Comprising (1r,4r)-6'-flouro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative In force Fee due Oct 26, 2027 Lapses if unpaid Apr 26, 2028 · High confidence | Adneuris Therapeutics, Inc. | In force | Oct 26, 2027 | Apr 26, 2028 | High confidence |
5 of 5 patents shown. Soonest fee due date first, then patent number.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.